MIP Discovery

Life Sciences  •    •  Growth

MIP Discovery develops and manufactures nanoMIPs, linear MIPs, bulk MIP and Rationally Designed Polymers using its proprietary processes. Molecularly Imprinted Polymers (MIPs) are ‘synthetic’ affinity reagents and the nanoMIP format provides a more robust alternative to antibodies, typically with similar or greater affinity coupled with additional unique characteristics. The company was previously known as MIP Diagnostics.

Company
information

Total BGF investment

£2 million

Investment date

Jul 2020

Head office

Bedfordshire

Chair

Jim Reid